Tauroursodeoxycholic acid administration as adjuvant therapy in cirrhotic patients on transplantation waiting lists

Hepato-Gastroenterology

Volumn 47, Issue 34, 2000, Pages 1045-1047

  Caglieris, S ^a   Giannini, E ^a   Dardano, G ^a   Mondello, L ^a   Valente, U ^a   Testa, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Liver transplantation; Tauroursodeoxy cholic acid

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; TAUROURSODEOXYCHOLIC ACID;

ADJUVANT THERAPY; ADULT; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; REGISTER;

CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; CHOLAGOGUES AND CHOLERETICS; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; TAUROCHENODEOXYCHOLIC ACID; TREATMENT OUTCOME; WAITING LISTS;

EID: 0033804664     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Monitoring and care of the patient before transplantation
2. Liver transplantation: Problems and perspectives
3. Ursodeoxycholic acid in chronic liver disease
4. Immunomodulatory effects of ursodeoxycholic acid on immune responses
5. Hepatoprotective properties of ursodeoxycholic acid
6. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats
7. Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rats
8. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis
9. Factors influencing waiting time and successful receipt of cadaveric liver transplant in the United States 1990 to 1992
10. Increased waiting time for liver transplantation results in higher mortality
11. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease
12. Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids
13. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolisis in rat hepatocytes
14. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts: In vivo studies in the rat
15. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis